By

Senators Rand Paul (R-KY), Cory Booker (D-NJ), and Kirsten Gillibrand (D-NY) today stood with patients, their families and advocates to announce new bipartisan legislation that will allow the use of medical...

By

In an ancient Indian parable, a group of blind men touches different parts of a large animal to find what it is. Only when they share the descriptions of an ear, tail, trunk and leg do they know it is...

By

Gov. Bobby Jindal and officials with the Louisiana Department of Health and Hospitals (DHH), and Louisiana State Police (LSP) announced the ban of a new synthetic marijuana compound called “5f-ADB”...

By

A team of researchers from Italy, Israel and the United Kingdom has succeeded in generating mature, functional skeletal muscles in mice using a new approach for tissue engineering. The scientists grew...

By

Approximately half of the more than 1,300 potential participants surveyed in the Minnesota Medical Cannabis program reported their qualifying condition as multiple sclerosis (MS) or severe muscle spasms. The...

By

Introduction of peanut products into the diets of infants at high risk of developing peanut allergy was safe and led to an 81 percent reduction in the subsequent development of the allergy, a clinical...

By

Daylight Saving Time starts Sunday, March 8 at 2 am and this can cause more trouble for some than you may think. “An hour seems like a minor change, but moving the clock ahead one hour can be very stressful...

By

A new study, published today in the Journal of Advanced Nursing, reveals that telephone-based peer support may help reduce postpartum depression in new mothers. Findings also indicate that social support...

By

The U.S. Food and Drug Administration today approved the VenaSeal closure system (VenaSeal system) to permanently treat varicose veins of the legs by sealing the affected superficial veins using an adhesive...

By

In an NIH-supported clinical trial comparing three drugs for diabetic macular edema (DME), Eylea (aflibercept) provided greater visual improvement, on average, than did Avastin (bevacizumab) or Lucentis...